Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

Alberto Borghetti; Arturo Ciccullo; Francesca Lombardi; Diana Giannarelli; Rosa Anna Passerotto; Francesco Lamanna; Antonella Carcagnì; Damiano Farinacci; Alex Dusina; Gianmaria Baldin; Maurizio Zazzi; Simona Di Giambenedetto

doi:10.1093/ofid/ofae198

Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

Alberto Borghetti, Arturo Ciccullo, Francesca Lombardi, Diana Giannarelli, Rosa Anna Passerotto, Francesco Lamanna, Antonella Carcagnì, Damiano Farinacci, Alex Dusina, Gianmaria Baldin, Maurizio Zazzi, Simona Di Giambenedetto

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Open Forum Infectious Diseases
Volume	11
DOI	https://doi.org/10.1093/ofid/ofae198
Stato di pubblicazione	Pubblicato - 2024

Keywords

HIV
lamivudine/dolutegravir
target trial emulation
three-drug regimen
virologically suppressed

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1093/ofid/ofae198

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

Borghetti, A., Ciccullo, A., Lombardi, F., Giannarelli, D., Passerotto, R. A., Lamanna, F., Carcagnì, A., Farinacci, D., Dusina, A., Baldin, G., Zazzi, M., & Di Giambenedetto, S. (2024). Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed. Open Forum Infectious Diseases, 11, N/A-N/A. https://doi.org/10.1093/ofid/ofae198

@article{8c72a831b9324848b13118e1d4367024,

title = "Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed",

keywords = "HIV, lamivudine/dolutegravir, target trial emulation, three-drug regimen, virologically suppressed, HIV, lamivudine/dolutegravir, target trial emulation, three-drug regimen, virologically suppressed",

author = "Alberto Borghetti and Arturo Ciccullo and Francesca Lombardi and Diana Giannarelli and Passerotto, {Rosa Anna} and Francesco Lamanna and Antonella Carcagn{\`i} and Damiano Farinacci and Alex Dusina and Gianmaria Baldin and Maurizio Zazzi and {Di Giambenedetto}, Simona",

year = "2024",

doi = "10.1093/ofid/ofae198",

language = "English",

volume = "11",

pages = "N/A--N/A",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

}

Borghetti, A, Ciccullo, A, Lombardi, F, Giannarelli, D, Passerotto, RA, Lamanna, F, Carcagnì, A, Farinacci, D, Dusina, A, Baldin, G, Zazzi, M & Di Giambenedetto, S 2024, 'Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed', Open Forum Infectious Diseases, vol. 11, pagg. N/A-N/A. https://doi.org/10.1093/ofid/ofae198

TY - JOUR

T1 - Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

AU - Borghetti, Alberto

AU - Ciccullo, Arturo

AU - Lombardi, Francesca

AU - Giannarelli, Diana

AU - Passerotto, Rosa Anna

AU - Lamanna, Francesco

AU - Carcagnì, Antonella

AU - Farinacci, Damiano

AU - Dusina, Alex

AU - Baldin, Gianmaria

AU - Zazzi, Maurizio

AU - Di Giambenedetto, Simona

PY - 2024

Y1 - 2024

KW - HIV

KW - lamivudine/dolutegravir

KW - target trial emulation

KW - three-drug regimen

KW - virologically suppressed

KW - HIV

KW - lamivudine/dolutegravir

KW - target trial emulation

KW - three-drug regimen

KW - virologically suppressed

UR - http://hdl.handle.net/10807/278227

U2 - 10.1093/ofid/ofae198

DO - 10.1093/ofid/ofae198

M3 - Article

SN - 2328-8957

VL - 11

SP - N/A-N/A

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

ER -